45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
18,753
Insurances with rates
54
CPT / HCPCS codes
13,486
Source MRF
Most expensive procedures (gross)
595144
$92,070
Injection, glatiramer acetate, 20 mg
Gross
$92,070
17196
$74,364
Not otherwise classified, antineoplastic drugs
Gross
$74,364
122606
$68,630
Indium in-111 pentetate, diagnostic, per 0.5 millicurie
Gross
$68,630
795971
$66,941
Injection, caplacizumab-yhdp, 1 mg
Gross
$66,941
595614
$49,687
Anti-inhibitor, per i.u.
Gross
$49,687
792646
$47,605
Injection, pembrolizumab, 1 mg
Gross
$47,605
795387
$42,881
Injection, atezolizumab, 10 mg
Gross
$42,881
792953
$35,935
Injection, trabectedin, 0.1 mg
Gross
$35,935
122625
$32,863
Strontium sr-89 chloride, therapeutic, per millicurie
Gross
$32,863
278
$32,000
Brachytherapy source, non-stranded, yttrium-90, per source
Gross
$32,000
792073
$31,145
Injection, vedolizumab, intravenous, 1 mg
Gross
$31,145
869152
$30,213
Integra flowable wound matrix, injectable, 1 cc
Gross
$30,213
7499
$29,501
Injection, reteplase, 18.1 mg
Gross
$29,501
7619
$25,911
Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
Gross
$25,911
596698
$22,244
Injection, belimumab, 10 mg
Gross
$22,244
115503
$21,145
Computed tomographic angiography, heart, coronary arteries and bypass grafts (when present), with co
Gross
$21,145
115747
$19,748
Endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrat
Gross
$19,748
159994
$19,748
Placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg,
Gross
$19,748
115746
$19,748
Endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrat
Gross
$19,748
115391
$17,173
Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuati
Gross
$17,173
115393
$17,173
Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuati
Gross
$17,173
115392
$17,173
Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuati
Gross
$17,173
115725
$16,916
Venography, superior sagittal sinus, radiological supervision and interpretation UNSCHEDULED
Gross
$16,916
121990
$16,856
Ventilation assist and management, initiation of pressure or volume preset ventilators for assisted
Gross
$16,856
121992
$16,856
Ventilation assist and management, initiation of pressure or volume preset ventilators for assisted
Gross
$16,856
122037
$16,856
Continuous positive airway pressure ventilation (CPAP), initiation and management UNSCHEDULED
Gross
$16,856
122620
$16,413
Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries
Gross
$16,413
121421
$16,047
Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep,
Gross
$16,047
121420
$16,047
Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep,
Gross
$16,047
121923
$15,316
Echocardiography, transesophageal (TEE) for monitoring purposes, including probe placement, real tim
Gross
$15,316
115499
$15,067
Computed tomography, heart, without contrast material, with quantitative evaluation of coronary calc
Gross
$15,067
3592
$14,958
Injection abciximab, 10 mg
Gross
$14,958
791306
$14,856
Injection, valrubicin, intravesical, 200 mg
Gross
$14,856
115387
$13,737
Brain imaging, positron emission tomography (PET); metabolic evaluation
Gross
$13,737
122574
$13,158
Indium in-111 satumomab pendetide, diagnostic, per study dose, up to 6 millicuries
Gross
$13,158
587291
$12,924
Injection, baclofen, 10 mg
Gross
$12,924
117531
$12,738
Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral
Gross
$12,738
117405
$12,738
Magnetic resonance angiography, head; without contrast material(s), followed by contrast material(s)
Gross
$12,738
117534
$12,738
Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardi
Gross
$12,738
117416
$12,738
Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphade
Gross
$12,738
117423
$12,738
Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, follo
Gross
$12,738
117424
$12,738
Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, follo
Gross
$12,738
117546
$12,738
Magnetic resonance angiography without contrast followed by with contrast, pelvis
Gross
$12,738
117425
$12,738
Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, follo
Gross
$12,738
117408
$12,738
Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s)
Gross
$12,738
594425
$12,738
Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents
Gross
$12,738
117411
$12,738
Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, fo
Gross
$12,738
117402
$12,738
Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), fol
Gross
$12,738
117472
$12,738
Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with con
Gross
$12,738
121916
$11,959
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording,
Gross
$11,959
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 595144 | Injection, glatiramer acetate, 20 mg | $92,070 | $92,070 | — | — | 3 |
| 17196 | Not otherwise classified, antineoplastic drugs | $74,364 | $74,364 | — | — | 3 |
| 122606 | Indium in-111 pentetate, diagnostic, per 0.5 millicurie | $68,630 | $68,630 | $1,230 | $1,230 | 1 |
| 795971 | Injection, caplacizumab-yhdp, 1 mg | $66,941 | $66,941 | — | — | 3 |
| 595614 | Anti-inhibitor, per i.u. | $49,687 | $49,687 | $2.33 | $2.33 | 4 |
| 792646 | Injection, pembrolizumab, 1 mg | $47,605 | $47,605 | $57.57 | $57.57 | 4 |
| 795387 | Injection, atezolizumab, 10 mg | $42,881 | $42,881 | $86.71 | $86.71 | 4 |
| 792953 | Injection, trabectedin, 0.1 mg | $35,935 | $35,935 | $353 | $353 | 4 |
| 122625 | Strontium sr-89 chloride, therapeutic, per millicurie | $32,863 | $32,863 | — | — | 3 |
| 278 | Brachytherapy source, non-stranded, yttrium-90, per source | $32,000 | $32,000 | $40,000 | $40,000 | 1 |
| 792073 | Injection, vedolizumab, intravenous, 1 mg | $31,145 | $31,145 | $20.53 | $20.53 | 4 |
| 869152 | Integra flowable wound matrix, injectable, 1 cc | $30,213 | $30,213 | $1,450 | $1,450 | 1 |
| 7499 | Injection, reteplase, 18.1 mg | $29,501 | $29,501 | — | — | 3 |
| 7619 | Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial | $25,911 | $25,911 | $2,016 | $2,016 | 4 |
| 596698 | Injection, belimumab, 10 mg | $22,244 | $22,244 | $53.32 | $53.32 | 4 |
| 115503 | Computed tomographic angiography, heart, coronary arteries and bypass grafts (when present), with co | $21,145 | $21,145 | $809 | $11,643 | 10 |
| 115747 | Endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrat | $19,748 | $19,748 | — | — | 1 |
| 159994 | Placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, | $19,748 | $19,748 | $2,433 | $2,484 | 3 |
| 115746 | Endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrat | $19,748 | $19,748 | $2,433 | $2,484 | 3 |
| 115391 | Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuati | $17,173 | $17,173 | $1,483 | $3,331 | 4 |
| 115393 | Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuati | $17,173 | $17,173 | $2,792 | $4,574 | 5 |
| 115392 | Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuati | $17,173 | $17,173 | $2,792 | $4,574 | 5 |
| 115725 | Venography, superior sagittal sinus, radiological supervision and interpretation UNSCHEDULED | $16,916 | $16,916 | $813 | $831 | 3 |
| 121990 | Ventilation assist and management, initiation of pressure or volume preset ventilators for assisted | $16,856 | $16,856 | $108 | $111 | 3 |
| 121992 | Ventilation assist and management, initiation of pressure or volume preset ventilators for assisted | $16,856 | $16,856 | $78.85 | $80.51 | 3 |
| 122037 | Continuous positive airway pressure ventilation (CPAP), initiation and management UNSCHEDULED | $16,856 | $16,856 | $698 | $713 | 3 |
| 122620 | Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries | $16,413 | $16,413 | $2,138 | $2,138 | 1 |
| 121421 | Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, | $16,047 | $16,047 | $6,396 | $6,530 | 3 |
| 121420 | Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, | $16,047 | $16,047 | — | — | 3 |
| 121923 | Echocardiography, transesophageal (TEE) for monitoring purposes, including probe placement, real tim | $15,316 | $15,316 | $517 | $528 | 3 |
| 115499 | Computed tomography, heart, without contrast material, with quantitative evaluation of coronary calc | $15,067 | $15,067 | $182 | $4,458 | 6 |
| 3592 | Injection abciximab, 10 mg | $14,958 | $14,958 | — | — | 3 |
| 791306 | Injection, valrubicin, intravesical, 200 mg | $14,856 | $14,856 | $1,401 | $1,401 | 4 |
| 115387 | Brain imaging, positron emission tomography (PET); metabolic evaluation | $13,737 | $13,737 | $2,792 | $4,574 | 5 |
| 122574 | Indium in-111 satumomab pendetide, diagnostic, per study dose, up to 6 millicuries | $13,158 | $13,158 | $2,766 | $2,766 | 1 |
| 587291 | Injection, baclofen, 10 mg | $12,924 | $12,924 | $170 | $170 | 4 |
| 117531 | Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 117405 | Magnetic resonance angiography, head; without contrast material(s), followed by contrast material(s) | $12,738 | $12,738 | $828 | $2,329 | 4 |
| 117534 | Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardi | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 117416 | Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphade | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 117423 | Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, follo | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 117424 | Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, follo | $12,738 | $12,738 | $828 | $2,329 | 4 |
| 117546 | Magnetic resonance angiography without contrast followed by with contrast, pelvis | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 117425 | Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, follo | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 117408 | Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 594425 | Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 117411 | Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, fo | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 117402 | Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), fol | $12,738 | $12,738 | $1,116 | $2,012 | 5 |
| 117472 | Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with con | $12,738 | $12,738 | $828 | $2,329 | 4 |
| 121916 | Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, | $11,959 | $11,959 | $1,948 | $1,989 | 3 |
Showing top 50 of 18,753 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.